Prenetics Global Limited (NASDAQ:PRENW) Short Interest Update

Prenetics Global Limited (NASDAQ:PRENW) was the recipient of a significant decline in short interest in April. As of April 15th, there was short interest totaling 3,360 shares, a decline of 43.5% from the March 31st total of 5,947 shares. Based on an average daily trading volume, of 8,157 shares, the days-to-cover ratio is currently 0.4 days.

Prenetics Global Stock Down 5.6%

Shares of PRENW stock traded down $0.00 during trading hours on Monday, hitting $0.02. 4,100 shares of the company were exchanged, compared to its average volume of 18,496. Prenetics Global has a 52 week low of $0.01 and a 52 week high of $0.07. The business has a 50 day moving average of $0.02 and a two-hundred day moving average of $0.02.

About Prenetics Global

Prenetics Global (NASDAQ: PRENW) is a molecular diagnostics and preventive genomics company that develops and delivers DNA-based tests and diagnostic solutions. The company’s offerings include direct-to-consumer health profiling services, clinical genetic tests, and pathogen screening assays. By combining advanced laboratory processes with digital tools, Prenetics aims to provide insights into genetic risk factors, nutrition and fitness optimization, and early disease detection.

Prenetics operates a portfolio of consumer genomics brands, including DNAFit and CircleDNA, which offer personalized reports on wellness, exercise, nutrition, and inherited health traits.